Healthy Volunteers Clinical Trial
— MASKOfficial title:
Memory, Auditory and Visual Attention in Healthy Children: Neurophysiological and Electrophysiological Aspects
This project studies memory and attention in healthy children aged from 5 to 17 years. The
processes investigated are short term memory (auditory and visual) and attention.
To characterize these processes involved in childhood, neuropsychological and
neurophysiological assessments will be performed (using Electro-encephalography measures,
behavioural responses and questionnaires).
Status | Recruiting |
Enrollment | 400 |
Est. completion date | October 6, 2020 |
Est. primary completion date | October 6, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 5 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Normal or corrected vision - No neurological and psychiatric antecedent. - No neuro-developmental disorder (dysphasia, dyslexia, dyspraxia, attention deficit disorder…) - Motivation to participate to the study - Signed parental informed consent authorizing their child to participate to the study Exclusion Criteria: - Children educated in a specialized institution. - Subjects diagnosed with a neurological, psychiatric or neuro-developmental disorder - Subjects with hearing loss - Subjects with a visual impairment that cannot be corrected - Subjects with an organic or chronic disease that can affect cognitive functions. - Subjects who do not benefit from social security. |
Country | Name | City | State |
---|---|---|---|
France | Hopital Femme Mère Enfant | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Neuropsychological tests: Proportion of accurate answers | 2 months | ||
Primary | Neuropsychological tests: reaction time of answers (seconds) | 2 months | ||
Primary | Neurophysiological tests: Event-related potentials in response to auditory and visual stimulations | 2 months | ||
Secondary | Proportion of accurate answers according to age range of children | 2 months | ||
Secondary | reaction time of answers (seconds) according to age range of children | 2 months | ||
Secondary | Event-related potentials in response to auditory and visual stimulations according to age range of children | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |